Stock listing
Dusseldorf:9UA NervGen Pharma Corp. Aktie
German listing (Dusseldorf) of NervGen Pharma Corp. · home listing NASDAQ:NGEN
Follow NervGen Pharma Corp. into a list and get an email when it puts out news.
Home listing price · NASDAQ:NGEN
$1.37 USD -0.07 (-4.9%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:NGEN
- Day range
- $1.35 – $1.50 USDOct 30, 2026
- Volume
- 526,463 sharesOct 30, 2026
- Market cap
- $147.3M USDAt the close on Oct 30, 2026 · price × 107.5M shares outstanding
- 52-week range
- $1.35 – $6.30 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $946,319 USDMedian day 437,650 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NGEN · Home | $1.37 USD | -0.07 (-4.9%) | 526,463 | $1.43 | $1.50 | $1.35 | $1.44 | Close on Oct 30, 2026 |
| Frankfurt:9UA | €1.28 EUR | +0.03 (+2.4%) | — | €1.22 | €1.28 | €1.22 | €1.25 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:NGEN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.37 | -0.07 | -4.9% | $1.43 | $1.50 | $1.35 | 526,463 | |
| $1.44 | -0.06 | -4.0% | $1.52 | $1.53 | $1.435 | 250,900 | |
| $1.50 | +0.02 | +1.4% | $1.50 | $1.55 | $1.45 | 309,200 | |
| $1.48 | +0.06 | +4.2% | $1.43 | $1.55 | $1.42 | 539,400 | |
| $1.42 | -0.01 | -0.7% | $1.43 | $1.45 | $1.37 | 259,200 | |
| $1.43 | +0.01 | +0.7% | $1.41 | $1.442 | $1.38 | 944,000 | |
| $1.42 | -0.08 | -5.3% | $1.50 | $1.51 | $1.415 | 628,400 | |
| $1.50 | -0.04 | -2.6% | $1.54 | $1.55 | $1.50 | 297,500 | |
| $1.54 | 0.00 | 0.0% | $1.53 | $1.589 | $1.52 | 228,400 | |
| $1.54 | -0.05 | -3.1% | $1.59 | $1.61 | $1.53 | 423,100 | |
| $1.59 | -0.03 | -1.9% | $1.63 | $1.66 | $1.58 | 388,300 | |
| $1.62 | +0.055 | +3.5% | $1.59 | $1.66 | $1.55 | 475,200 | |
| $1.565 | -0.065 | -4.0% | $1.65 | $1.65 | $1.55 | 1,298,900 | |
| $1.63 | -0.10 | -5.8% | $1.74 | $1.792 | $1.615 | 506,400 | |
| $1.73 | 0.00 | 0.0% | $1.75 | $1.79 | $1.71 | 220,500 | |
| $1.73 | -0.02 | -1.1% | $1.75 | $1.80 | $1.705 | 293,200 | |
| $1.75 | +0.01 | +0.6% | $1.74 | $1.81 | $1.72 | 288,900 | |
| $1.74 | -0.01 | -0.6% | $1.78 | $1.785 | $1.73 | 231,500 | |
| $1.75 | -0.06 | -3.3% | $1.81 | $1.82 | $1.73 | 297,800 | |
| $1.81 | +0.03 | +1.7% | $1.78 | $1.88 | $1.78 | 441,000 | |
| $1.78 | +0.02 | +1.1% | $1.78 | $1.90 | $1.74 | 403,600 | |
| $1.76 | -0.15 | -7.9% | $1.92 | $1.92 | $1.73 | 1,049,400 | |
| $1.91 | -0.01 | -0.5% | $1.91 | $1.98 | $1.90 | 548,400 | |
| $1.92 | +0.04 | +2.1% | $1.86 | $1.96 | $1.84 | 556,800 | |
| $1.88 | -0.06 | -3.1% | $1.89 | $1.99 | $1.88 | 525,400 | |
| $1.94 | -0.08 | -4.0% | $2.00 | $2.01 | $1.915 | 343,200 | |
| $2.02 | +0.06 | +3.1% | $1.98 | $2.02 | $1.91 | 316,900 | |
| $1.96 | -0.105 | -5.1% | $2.05 | $2.093 | $1.955 | 536,300 | |
| $2.065 | +0.075 | +3.8% | $2.00 | $2.10 | $1.99 | 223,500 | |
| $1.99 | -0.06 | -2.9% | $2.06 | $2.06 | $1.96 | 473,600 | |
| $2.05 | -0.22 | -9.7% | $2.27 | $2.27 | $2.04 | 607,500 | |
| $2.27 | +0.14 | +6.6% | $2.15 | $2.33 | $2.09 | 1,159,400 | |
| $2.13 | -0.01 | -0.5% | $2.16 | $2.18 | $2.08 | 452,900 | |
| $2.14 | -0.055 | -2.5% | $2.19 | $2.19 | $2.11 | 323,000 | |
| $2.195 | +0.01 | +0.5% | $2.18 | $2.25 | $2.175 | 238,300 | |
| $2.185 | +0.025 | +1.2% | $2.17 | $2.23 | $2.14 | 559,000 | |
| $2.16 | +0.03 | +1.4% | $2.10 | $2.165 | $2.07 | 313,800 | |
| $2.13 | -0.06 | -2.7% | $2.19 | $2.27 | $2.115 | 366,100 | |
| $2.19 | -0.14 | -6.0% | $2.32 | $2.345 | $2.16 | 713,700 | |
| $2.33 | +0.01 | +0.4% | $2.31 | $2.395 | $2.275 | 920,500 | |
| $2.32 | -0.01 | -0.4% | $2.34 | $2.36 | $2.275 | 434,300 | |
| $2.33 | +0.01 | +0.4% | $2.32 | $2.36 | $2.31 | 383,100 | |
| $2.32 | +0.11 | +5.0% | $2.21 | $2.37 | $2.10 | 1,057,800 | |
| $2.21 | -0.07 | -3.1% | $2.27 | $2.30 | $2.13 | 798,300 | |
| $2.28 | -0.055 | -2.4% | $2.34 | $2.40 | $2.245 | 868,900 | |
| $2.335 | +0.125 | +5.7% | $2.19 | $2.39 | $2.125 | 978,700 | |
| $2.21 | +0.13 | +6.2% | $2.09 | $2.22 | $2.00 | 467,700 | |
| $2.08 | +0.08 | +4.0% | $1.98 | $2.105 | $1.96 | 911,300 | |
| $2.00 | +0.14 | +7.5% | $1.96 | $2.00 | $1.82 | 1,105,900 | |
| $1.86 | +0.10 | +5.7% | $1.78 | $1.86 | $1.727 | 541,500 | |
| $1.76 | +0.01 | +0.6% | $1.75 | $1.77 | $1.685 | 253,000 | |
| $1.75 | +0.04 | +2.3% | $1.68 | $1.775 | $1.68 | 493,100 | |
| $1.71 | +0.03 | +1.8% | $1.68 | $1.72 | $1.63 | 378,400 | |
| $1.68 | -0.055 | -3.2% | $1.68 | $1.695 | $1.63 | 501,900 | |
| $1.735 | -0.025 | -1.4% | $1.78 | $1.78 | $1.655 | 562,900 | |
| $1.76 | 0.00 | 0.0% | $1.77 | $1.82 | $1.733 | 553,000 | |
| $1.76 | +0.02 | +1.1% | $1.75 | $1.79 | $1.725 | 387,000 | |
| $1.74 | +0.04 | +2.4% | $1.71 | $1.76 | $1.71 | 202,100 | |
| $1.70 | -0.01 | -0.6% | $1.73 | $1.74 | $1.695 | 354,300 | |
| $1.71 | -0.01 | -0.6% | $1.73 | $1.747 | $1.68 | 278,100 | |
| $1.72 | +0.04 | +2.4% | $1.68 | $1.76 | $1.66 | 343,600 | |
| $1.68 | +0.02 | +1.2% | $1.66 | $1.75 | $1.64 | 597,100 | |
| $1.66 | +0.02 | +1.2% | $1.63 | $1.72 | $1.63 | 362,700 | |
| $1.64 | +0.02 | +1.2% | $1.63 | $1.68 | $1.605 | 238,000 | |
| $1.62 | +0.02 | +1.3% | $1.66 | $1.66 | $1.59 | 299,800 | |
| $1.60 | +0.01 | +0.6% | $1.60 | $1.66 | $1.59 | 220,500 |
- Ticker
- Dusseldorf:9UA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Dusseldorf
- Currency
- EUR
What changed lately
Latest news release · Oct 12, 2026
NervGen Announces First Participant Dosed in RESTORE, a Phase 3 Registrational Study Evaluating NVG-291 in Chronic Spinal Cord Injury
Latest deck · Sep 30, 2026
Investor Day (September 2026)
Investor day · 99 slides
Latest news
NervGen Announces First Participant Dosed in RESTORE, a Phase 3 Registrational Study Evaluating NVG-291 in Chronic Spinal Cord Injury
Oct 12, 2026
Closed $1.73 (0.0%) on Oct 12, 2026
NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments
Sep 25, 2026
Closed $1.88 (-3.1%) on Sep 28, 2026
NervGen to Host Inaugural R&D Day on September 30, 2026
Sep 9, 2026
Closed $2.13 (-2.7%) on Sep 9, 2026
NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates
Aug 13, 2026
Closed $1.76 (0.0%) on Aug 13, 2026
NervGen Announces Positive Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery with NVG-291 in Phase 1b/2a CONNECT SCI Study
May 26, 2026
Closed $2.13 (+2.4%) on May 26, 2026
NervGen Announces Pricing of US$60.0 Million Public Offering of Securities
May 21, 2026
Closed $2.08 (-43.5%) on May 22, 2026
NervGen Announces Proposed Public Offering of Securities
May 21, 2026
Closed $2.08 (-43.5%) on May 22, 2026
NervGen Reports First Quarter 2026 Financial Results and Provides Business Updates
May 18, 2026
Closed $3.64 (+2.1%) on May 18, 2026
NervGen Pharma Strengthens Leadership Team with Appointment of Keith Vendola as Chief Financial Officer
Apr 27, 2026
Closed $3.85 (-1.8%) on Apr 27, 2026
Financings
At-the-market programme of common shares
Aug 13, 2026
Announced: up to US$50M · Leerink Partners LLC
Dealers: Leerink Partners LLC (lead)
Decks
Investor Day (September 2026)
Investor day · 99 slides · Sep 30, 2026
Investor Presentation (May 2026)
Investor deck · 35 slides · May 21, 2026
Investor Presentation (May 2026)
Investor deck · 36 slides · May 2026
Investor Presentation (May 2026)
Investor deck · 28 slides · May 2026
NervGen Pharma Corp. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 20 in the last 12 months · 20 in all · newest Oct 12, 2026 · oldest 2026
- Decks
- 33 decks · latest Sep 30, 2026
Where NervGen Pharma Corp. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NGEN · Home listing | NASDAQ | United States | USD |
| gettex:9UA | gettex | Germany | EUR |
| BOATS:NGEN | BOATS | United States | USD |
| Tradegate:9UA | Tradegate | Germany | EUR |
| Lang & Schwarz:A2QP3D | Lang & Schwarz | Germany | EUR |
| LS Exchange:A2QP3D | LS Exchange | Germany | EUR |
| Frankfurt:9UA | Frankfurt | Germany | EUR |
| Dusseldorf:9UA · This page | Dusseldorf | Germany | EUR |
| Hamburg:9UA | Hamburg | Germany | EUR |
| Munich:9UA | Munich | Germany | EUR |
| Stuttgart:9UA | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about NervGen Pharma Corp.